Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1118741

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1118741

Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 109 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the CRISPR and CRISPR-Associated (Cas) Genes Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Genome Editing
    • 1.2.3 Genetic engineering
    • 1.2.4 gRNA Database/Gene Librar
    • 1.2.5 CRISPR Plasmid
    • 1.2.6 Human Stem Cells
    • 1.2.7 Genetically Modified Organisms/Crops
    • 1.2.8 Cell Line Engineering
  • 1.3 Market by Application
    • 1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Biotechnology Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Academic Institutes
    • 1.3.5 Research and Development Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2017-2028)
  • 2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
    • 2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2017-2022)
    • 2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028)
  • 2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
    • 2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
    • 2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
    • 2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
    • 2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
    • 3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2017-2022)
    • 3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2022)
  • 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
  • 3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
    • 3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
  • 3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
  • 3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
  • 3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type

  • 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2017-2022)
  • 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028)

5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application

  • 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2017-2022)
  • 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
    • 8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.1.5 Thermo Fisher Scientific Recent Developments
  • 11.2 Editas Medicine
    • 11.2.1 Editas Medicine Company Details
    • 11.2.2 Editas Medicine Business Overview
    • 11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.2.5 Editas Medicine Recent Developments
  • 11.3 Caribou Biosciences
    • 11.3.1 Caribou Biosciences Company Details
    • 11.3.2 Caribou Biosciences Business Overview
    • 11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.3.5 Caribou Biosciences Recent Developments
  • 11.4 CRISPR therapeutics
    • 11.4.1 CRISPR therapeutics Company Details
    • 11.4.2 CRISPR therapeutics Business Overview
    • 11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.4.5 CRISPR therapeutics Recent Developments
  • 11.5 Intellia therapeutics, Inc.
    • 11.5.1 Intellia therapeutics, Inc. Company Details
    • 11.5.2 Intellia therapeutics, Inc. Business Overview
    • 11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.5.5 Intellia therapeutics, Inc. Recent Developments
  • 11.6 Cellectis
    • 11.6.1 Cellectis Company Details
    • 11.6.2 Cellectis Business Overview
    • 11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.6.5 Cellectis Recent Developments
  • 11.7 Horizon Discovery Plc
    • 11.7.1 Horizon Discovery Plc Company Details
    • 11.7.2 Horizon Discovery Plc Business Overview
    • 11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.7.5 Horizon Discovery Plc Recent Developments
  • 11.8 Sigma Aldrich
    • 11.8.1 Sigma Aldrich Company Details
    • 11.8.2 Sigma Aldrich Business Overview
    • 11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.8.5 Sigma Aldrich Recent Developments
  • 11.9 Precision Biosciences
    • 11.9.1 Precision Biosciences Company Details
    • 11.9.2 Precision Biosciences Business Overview
    • 11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.9.5 Precision Biosciences Recent Developments
  • 11.10 Genscript
    • 11.10.1 Genscript Company Details
    • 11.10.2 Genscript Business Overview
    • 11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.10.5 Genscript Recent Developments
  • 11.11 Sangamo Biosciences Inc.
    • 11.11.1 Sangamo Biosciences Inc. Company Details
    • 11.11.2 Sangamo Biosciences Inc. Business Overview
    • 11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.11.5 Sangamo Biosciences Inc. Recent Developments
  • 11.12 Lonza Group Limited
    • 11.12.1 Lonza Group Limited Company Details
    • 11.12.2 Lonza Group Limited Business Overview
    • 11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.12.5 Lonza Group Limited Recent Developments
  • 11.13 Integrated DNA Technologies
    • 11.13.1 Integrated DNA Technologies Company Details
    • 11.13.2 Integrated DNA Technologies Business Overview
    • 11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.13.5 Integrated DNA Technologies Recent Developments
  • 11.14 New England Biolabs
    • 11.14.1 New England Biolabs Company Details
    • 11.14.2 New England Biolabs Business Overview
    • 11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.14.5 New England Biolabs Recent Developments
  • 11.15 Origene Technologies
    • 11.15.1 Origene Technologies Company Details
    • 11.15.2 Origene Technologies Business Overview
    • 11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.15.5 Origene Technologies Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Genome Editing
    • 1.2.3 Genetic engineering
    • 1.2.4 gRNA Database/Gene Librar
    • 1.2.5 CRISPR Plasmid
    • 1.2.6 Human Stem Cells
    • 1.2.7 Genetically Modified Organisms/Crops
    • 1.2.8 Cell Line Engineering
  • 1.3 Market by Application
    • 1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Biotechnology Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Academic Institutes
    • 1.3.5 Research and Development Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2017-2028)
  • 2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
    • 2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2017-2022)
    • 2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028)
  • 2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
    • 2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
    • 2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
    • 2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
    • 2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
    • 3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2017-2022)
    • 3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2022)
  • 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
  • 3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
    • 3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
  • 3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
  • 3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
  • 3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type

  • 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2017-2022)
  • 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028)

5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application

  • 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2017-2022)
  • 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
    • 8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
  • 10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.1.5 Thermo Fisher Scientific Recent Developments
  • 11.2 Editas Medicine
    • 11.2.1 Editas Medicine Company Details
    • 11.2.2 Editas Medicine Business Overview
    • 11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.2.5 Editas Medicine Recent Developments
  • 11.3 Caribou Biosciences
    • 11.3.1 Caribou Biosciences Company Details
    • 11.3.2 Caribou Biosciences Business Overview
    • 11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.3.5 Caribou Biosciences Recent Developments
  • 11.4 CRISPR therapeutics
    • 11.4.1 CRISPR therapeutics Company Details
    • 11.4.2 CRISPR therapeutics Business Overview
    • 11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.4.5 CRISPR therapeutics Recent Developments
  • 11.5 Intellia therapeutics, Inc.
    • 11.5.1 Intellia therapeutics, Inc. Company Details
    • 11.5.2 Intellia therapeutics, Inc. Business Overview
    • 11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.5.5 Intellia therapeutics, Inc. Recent Developments
  • 11.6 Cellectis
    • 11.6.1 Cellectis Company Details
    • 11.6.2 Cellectis Business Overview
    • 11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.6.5 Cellectis Recent Developments
  • 11.7 Horizon Discovery Plc
    • 11.7.1 Horizon Discovery Plc Company Details
    • 11.7.2 Horizon Discovery Plc Business Overview
    • 11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.7.5 Horizon Discovery Plc Recent Developments
  • 11.8 Sigma Aldrich
    • 11.8.1 Sigma Aldrich Company Details
    • 11.8.2 Sigma Aldrich Business Overview
    • 11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.8.5 Sigma Aldrich Recent Developments
  • 11.9 Precision Biosciences
    • 11.9.1 Precision Biosciences Company Details
    • 11.9.2 Precision Biosciences Business Overview
    • 11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.9.5 Precision Biosciences Recent Developments
  • 11.10 Genscript
    • 11.10.1 Genscript Company Details
    • 11.10.2 Genscript Business Overview
    • 11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.10.5 Genscript Recent Developments
  • 11.11 Sangamo Biosciences Inc.
    • 11.11.1 Sangamo Biosciences Inc. Company Details
    • 11.11.2 Sangamo Biosciences Inc. Business Overview
    • 11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.11.5 Sangamo Biosciences Inc. Recent Developments
  • 11.12 Lonza Group Limited
    • 11.12.1 Lonza Group Limited Company Details
    • 11.12.2 Lonza Group Limited Business Overview
    • 11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.12.5 Lonza Group Limited Recent Developments
  • 11.13 Integrated DNA Technologies
    • 11.13.1 Integrated DNA Technologies Company Details
    • 11.13.2 Integrated DNA Technologies Business Overview
    • 11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.13.5 Integrated DNA Technologies Recent Developments
  • 11.14 New England Biolabs
    • 11.14.1 New England Biolabs Company Details
    • 11.14.2 New England Biolabs Business Overview
    • 11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.14.5 New England Biolabs Recent Developments
  • 11.15 Origene Technologies
    • 11.15.1 Origene Technologies Company Details
    • 11.15.2 Origene Technologies Business Overview
    • 11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
    • 11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    • 11.15.5 Origene Technologies Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
  • Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Genome Editing
  • Table 3. Key Players of Genetic engineering
  • Table 4. Key Players of gRNA Database/Gene Librar
  • Table 5. Key Players of CRISPR Plasmid
  • Table 6. Key Players of Human Stem Cells
  • Table 7. Key Players of Genetically Modified Organisms/Crops
  • Table 8. Key Players of Cell Line Engineering
  • Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
  • Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2017-2022)
  • Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2023-2028)
  • Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
  • Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
  • Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
  • Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
  • Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2017-2022) & (US$ Million)
  • Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2017-2022)
  • Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
  • Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2021
  • Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2017-2022)
  • Table 24. Key Players Headquarters and Area Served
  • Table 25. Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
  • Table 26. Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2017-2022)
  • Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2023-2028)
  • Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2017-2022)
  • Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2023-2028)
  • Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
  • Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
  • Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
  • Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
  • Table 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
  • Table 44. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 45. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
  • Table 46. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
  • Table 47. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
  • Table 52. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
  • Table 53. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028) & (US$ Million)
  • Table 54. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 55. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
  • Table 56. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 57. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
  • Table 58. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
  • Table 59. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
  • Table 64. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
  • Table 65. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
  • Table 66. Thermo Fisher Scientific Company Details
  • Table 67. Thermo Fisher Scientific Business Overview
  • Table 68. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 69. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 70. Thermo Fisher Scientific Recent Developments
  • Table 71. Editas Medicine Company Details
  • Table 72. Editas Medicine Business Overview
  • Table 73. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 74. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 75. Editas Medicine Recent Developments
  • Table 76. Caribou Biosciences Company Details
  • Table 77. Caribou Biosciences Business Overview
  • Table 78. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 79. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 80. Caribou Biosciences Recent Developments
  • Table 81. CRISPR therapeutics Company Details
  • Table 82. CRISPR therapeutics Business Overview
  • Table 83. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 84. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 85. CRISPR therapeutics Recent Developments
  • Table 86. Intellia therapeutics, Inc. Company Details
  • Table 87. Intellia therapeutics, Inc. Business Overview
  • Table 88. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 89. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 90. Intellia therapeutics, Inc. Recent Developments
  • Table 91. Cellectis Company Details
  • Table 92. Cellectis Business Overview
  • Table 93. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 94. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 95. Cellectis Recent Developments
  • Table 96. Horizon Discovery Plc Company Details
  • Table 97. Horizon Discovery Plc Business Overview
  • Table 98. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 99. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 100. Horizon Discovery Plc Recent Developments
  • Table 101. Sigma Aldrich Company Details
  • Table 102. Sigma Aldrich Business Overview
  • Table 103. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 104. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 105. Sigma Aldrich Recent Developments
  • Table 106. Precision Biosciences Company Details
  • Table 107. Precision Biosciences Business Overview
  • Table 108. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 109. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 110. Precision Biosciences Recent Developments
  • Table 111. Genscript Company Details
  • Table 112. Genscript Business Overview
  • Table 113. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 114. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 115. Genscript Recent Developments
  • Table 116. Sangamo Biosciences Inc. Company Details
  • Table 117. Sangamo Biosciences Inc. Business Overview
  • Table 118. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 119. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 120. Sangamo Biosciences Inc. Recent Developments
  • Table 121. Lonza Group Limited Company Details
  • Table 122. Lonza Group Limited Business Overview
  • Table 123. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 124. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 125. Lonza Group Limited Recent Developments
  • Table 126. Integrated DNA Technologies Company Details
  • Table 127. Integrated DNA Technologies Business Overview
  • Table 128. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 129. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 130. Integrated DNA Technologies Recent Developments
  • Table 131. New England Biolabs Company Details
  • Table 132. New England Biolabs Business Overview
  • Table 133. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 134. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 135. New England Biolabs Recent Developments
  • Table 136. Origene Technologies Company Details
  • Table 137. Origene Technologies Business Overview
  • Table 138. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
  • Table 139. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
  • Table 140. Origene Technologies Recent Developments
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2021 VS 2028
  • Figure 2. Genome Editing Features
  • Figure 3. Genetic engineering Features
  • Figure 4. gRNA Database/Gene Librar Features
  • Figure 5. CRISPR Plasmid Features
  • Figure 6. Human Stem Cells Features
  • Figure 7. Genetically Modified Organisms/Crops Features
  • Figure 8. Cell Line Engineering Features
  • Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2021 VS 2028
  • Figure 10. Biotechnology Companies Case Studies
  • Figure 11. Pharmaceutical Companies Case Studies
  • Figure 12. Academic Institutes Case Studies
  • Figure 13. Research and Development Institutes Case Studies
  • Figure 14. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
  • Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2021 VS 2028
  • Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2021
  • Figure 19. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
  • Figure 20. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
  • Figure 21. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
  • Figure 23. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
  • Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
  • Figure 25. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
  • Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
  • Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
  • Figure 30. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
  • Figure 31. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
  • Figure 38. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
  • Figure 39. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
  • Figure 40. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Region (2017-2028)
  • Figure 41. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
  • Figure 49. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
  • Figure 50. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
  • Figure 51. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
  • Figure 54. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
  • Figure 55. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
  • Figure 56. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
  • Figure 57. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 59. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 61. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 62. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 63. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 64. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 65. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 66. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 67. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 68. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 69. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 70. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 71. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 72. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 73. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 74. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
  • Figure 75. Bottom-up and Top-down Approaches for This Report
  • Figure 76. Data Triangulation
  • Figure 77. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!